Ethyl dirazepate

Ethyl dirazepate
Systematic (IUPAC) name
ethyl 7-chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate
Identifiers
CAS Number 23980-14-5 YesY
PubChem CID 208941
ChemSpider 181035
UNII 74FAA305EW N
ChEMBL CHEMBL2106231 N
Chemical data
Formula C18H14Cl2N2O3
Molar mass 377.221
 NYesY (what is this?)  (verify)

Ethyl dirazepate[1] is a drug which is a benzodiazepine derivative which was developed by Sanofi Winthrop. It has anxiolytic and hypnotic and possibly other characteristic benzodiazepine properties.[2][3][4]

See also

References

  1. ZA Patent 6804601
  2. "ethyl dirazepate". psychotropics.dk. 2003. Retrieved 7 December 2009.
  3. "Drugs of the Future". Thomson Reuters 6 (11). November 1981.
  4. "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities (eur-lex.europa.eu). 23 October 2001. Retrieved 7 December 2009.
This article is issued from Wikipedia - version of the Wednesday, April 20, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.